NCT05335174 Hypotension Prediction Index in Postoperative Surgical Patients
| NCT ID | NCT05335174 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sir Mortimer B. Davis - Jewish General Hospital |
| Condition | Surgery |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2022-04-01 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2022-04-01 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
PACU-HPI study evaluates the use of a hemodynamic monitor in the post-anesthetic recovery room on patients undergoing colorectal, hepatobiliary, and vascular surgery, to determine the feasibility of recruiting this surgical population.
Eligibility Criteria
Inclusion Criteria: 1. Patient ≥45 years old 2. Will undergo open colorectal, hepatobiliary, or vascular surgery; 3. Is expected to have an arterial cannula inserted intraoperatively; 4. Has an anticipated stay in PACU for at least 2 hours; 5. Able to provide written informed consent Exclusion Criteria: 1. Planned admission to ICU; 2. Refusal to participate; 3. Previously enrolled in the study
Contact & Investigator
Stephen Yang, MD, MSc
PRINCIPAL INVESTIGATOR
Jewish General Hospital
Frequently Asked Questions
Who can join the NCT05335174 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, studying Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05335174 currently recruiting?
Yes, NCT05335174 is actively recruiting participants. Contact the research team at stephen.yang@mail.mcgill.ca for enrollment information.
Where is the NCT05335174 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT05335174 clinical trial?
NCT05335174 is sponsored by Sir Mortimer B. Davis - Jewish General Hospital. The principal investigator is Stephen Yang, MD, MSc at Jewish General Hospital. The trial plans to enroll 30 participants.